STRS Ohio’s ALX Oncology ALXO Stock Holding History

STRS Ohio’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,100	Closed	-$2.55K	–	2200
2025 Q1	$2.55K	Hold	4,100	–	–	﹤0.01%	1910
2024 Q4	$6.85K	Hold	4,100	–	–	﹤0.01%	1856
2024 Q3	$7.46K	Hold	4,100	–	–	﹤0.01%	1936
2024 Q2	$24.7K	Buy	+4,100	New	+$50.4K	﹤0.01%	1879
2023 Q1	–	Sell	-500	Closed	-$5K	–	1941
2022 Q4	$5K	Hold	500	–	–	﹤0.01%	1950
2022 Q3	$4K	Hold	500	–	–	﹤0.01%	1990
2022 Q2	$4K	Hold	500	–	–	﹤0.01%	2016
2022 Q1	$8K	Hold	500	–	–	﹤0.01%	2101
2021 Q4	$10K	Hold	500	–	–	﹤0.01%	2152
2021 Q3	$36K	Buy	+500	New	+$33.3K	﹤0.01%	2114
2021 Q2	–	Sell	-9,900	Closed	-$730K	–	2228
2021 Q1	$730K	Buy	9,900 +7,500	+313%	+$590K	﹤0.01%	1396
2020 Q4	$206K	Hold	2,400	–	–	﹤0.01%	1734
2020 Q3	$90K	Buy	+2,400	New	+$94.3K	﹤0.01%	1864

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

STRS Ohio's ALXO Position: Q2 2025 in Review

STRS Ohio sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 4,100 shares — an estimated $2.55K sold.

STRS Ohio first reported a position in ALXO in Q3 2020 and held it in 13 quarters. The position peaked at $730K in Q1 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

STRS Ohio reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
STRS Ohio sold 4,100 ALX Oncology shares in Q2 2025, an estimated $2.55K.
STRS Ohio first reported a position in ALX Oncology in Q3 2020 and held it in 13 quarters.
STRS Ohio's ALX Oncology position peaked at $730K in Q1 2021.
61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.